U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.2T>C (p.Met1Thr) AND Hypercholesterolemia, familial, 1

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Apr 22, 2022
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000509477.5

Allele description [Variation Report for NM_000527.5(LDLR):c.2T>C (p.Met1Thr)]

NM_000527.5(LDLR):c.2T>C (p.Met1Thr)

Genes:
LDLR-AS1:LDLR antisense RNA 1 [Gene - HGNC]
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.2T>C (p.Met1Thr)
Other names:
NM_000527.5(LDLR):c.2T>C; p.Met1Thr
HGVS:
  • NC_000019.10:g.11089550T>C
  • NG_009060.1:g.5170T>C
  • NM_000527.5:c.2T>CMANE SELECT
  • NM_001195798.2:c.2T>C
  • NM_001195799.2:c.2T>C
  • NM_001195800.2:c.2T>C
  • NM_001195803.2:c.2T>C
  • NP_000518.1:p.Met1Thr
  • NP_000518.1:p.Met1Thr
  • NP_001182727.1:p.Met1Thr
  • NP_001182728.1:p.Met1Thr
  • NP_001182729.1:p.Met1Thr
  • NP_001182732.1:p.Met1Thr
  • LRG_274t1:c.2T>C
  • LRG_274:g.5170T>C
  • LRG_274p1:p.Met1Thr
  • NC_000019.9:g.11200226T>C
  • NM_000527.4:c.2T>C
  • NR_163945.1:n.110A>G
Protein change:
M1T
Links:
dbSNP: rs1555800701
NCBI 1000 Genomes Browser:
rs1555800701
Molecular consequence:
  • NM_000527.5:c.2T>C - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_001195798.2:c.2T>C - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_001195799.2:c.2T>C - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_001195800.2:c.2T>C - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_001195803.2:c.2T>C - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_000527.5:c.2T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.2T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.2T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.2T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.2T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_163945.1:n.110A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000607400Fundacion Hipercolesterolemia Familiar - SAFEHEART
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 1, 2016)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

SCV002506385ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel
reviewed by expert panel

(ClinGen FH ACMG Specifications v1-2)
Likely pathogenic
(Apr 22, 2022)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedresearch, curation

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fundacion Hipercolesterolemia Familiar - SAFEHEART, SCV000607400.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel, SCV002506385.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The NM_000527.5(LDLR):c.2T>C (p.Met1Thr) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying evidence codes PM2, PVS1_Moderate, and PM5 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012) The supporting evidence is as follows: PM2 - variant is absent from gnomAD (v2.1.1). PVS1_Moderate – variant is predicted to affect the initiation codon. PM5 - four other missense variants at this same codon have been reported, and one is Pathogenic: 1) NM_000527.5(LDLR):c.1A>C (p.Met1Leu) – Pathogenic by these guidelines. 2) NM_000527.5(LDLR):c.1A>G (p.Met1Val) - Likely pathogenic by these guidelines. 3) NM_000527.4(LDLR):c.3G>A (p.Met1Ile) - Likely pathogenic by these guidelines. 4) NM_000527.5(LDLR):c.3G>T (p.Met1Ile) - Likely pathogenic by these guidelines.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 23, 2024